Background: Obesity results from a chronic imbalance between energy
intake and energy expenditure. Total energy expenditure for all physiological
functions combined can be measured approximately by calorimeters. These devices
assess energy expenditure frequently (e.g., in 60-second epochs), resulting in
massive complex data that are nonlinear functions of time. To reduce the
prevalence of obesity, researchers often design targeted therapeutic
interventions to increase daily energy expenditure. Methods: We analyzed
previously collected data on the effects of oral interferon tau supplementation
on energy expenditure, as assessed with indirect calorimeters, in an animal model
for obesity and type 2 diabetes (Zucker diabetic fatty rats). In our statistical
analyses, we compared parametric polynomial mixed effects models and more
flexible semiparametric models involving spline regression. Results: We
found no effect of interferon tau dose (0 vs. 4
